Bio-Rad Laboratories Class BBIO.B
13F holders, Q4 2024 (December 31)8holders +2
2new positions
0sold out
$325.66avg. 13F price*
At the end of Q4 2024, 8 institutions reported holding Bio-Rad Laboratories Class B (BIO.B) in their 13F filings, up 2 from Q3 2024. 2 opened new positions and 0 sold out. The largest holders were CSS LLC ($441K), Focus Partners Wealth ($245K) and Morgan Stanley ($230K).
- Company
- Bio-Rad Laboratories Class B
- CUSIP
- 090572108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $42K |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 128 shares bought and 151 shares sold, net −23 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| CSS LLC | 0.08% | Reduce -10.1% | 1,341 | $441K |
| Focus Partners Wealth | 0.00% | No change | 760 | $245K |
| Morgan Stanley | 0.00% | No change | 712 | $230K |
| Wells Fargo & Company | 0.00% | No change | 170 | $55K |
| Whittier Trust Co. | 0.00% | No change | 160 | $52K |
| Itau Unibanco Holding S.A. | 0.00% | New | 127 | $42K |
| Jones Financial Companies LLLP | 0.00% | No change | 38 | $13K |
| UBS Group AG | 0.00% | New | 1 | $323 |
"% of holder's portfolio" is BIO.B's weight in each manager's 13F, not the share of Bio-Rad Laboratories Class B the manager owns.